Newsroom | 3869 results

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that Kristin Peck, Chief Executive Officer, and Jay Saccaro, EVP, Chief Financial Officer and Chief Operating Officer, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026 at 1:50 p.m. ET. Interested parties can access the live audio webcast of the presentation by visiting https://investor.zoetis.com/events-presentations. A replay will also be ava...

NORTH CANTON, Ohio--(BUSINESS WIRE)--CATalyst Council today marked the start of Happy, Healthy Cat Month with the release of a new downloadable resource for veterinary practices, “The Kitten in the Room: Turning Kitten Season into Lifelong Feline Care.” Authored by Kristin Wuhrman, CCBC, and Gina Fortunato, MBA, the article draws on CATalyst's 2026 State of the Cat report, the largest cat household survey ever conducted. The article examines why many cats fall out of veterinary care after their...

DENVER--(BUSINESS WIRE)--Paw Prosper, a leading provider of innovative, veterinarian-recommended solutions and education, today announced an expanded partnership with Elvation Medical, becoming the exclusive home and commercial partner for Elvation VET Shockwave Therapy across the United States and Canada. This landmark agreement brings Elvation’s flagship veterinary device, the PiezoWave2T VET, directly into the Paw Prosper portfolio. Engineered in Germany and assembled in the USA, the PiezoWa...

PLEASANTON, Calif.--(BUSINESS WIRE)--Twelve animal well-being organizations across the Bay Area are joining forces once again to provide free spay and neuter surgeries, vaccines, microchips and other essential veterinary services to pets through Champions for Pet Health: Communities Partnering for Wellness and Spay & Neuter. The three-day event will take place September 25–27, 2026, and is made possible through the generosity of three national family foundations: La Russa Rescue Champions,...

PLANTATION, Fla.--(BUSINESS WIRE)--Chewy, Inc. (NYSE: CHWY) (“Chewy”), a trusted destination for pet parents and partners everywhere, announced today that Sumit Singh, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs Global Consumer and Retail Conference 2026 on September 14, 2026 at 2:50 PM ET. A live audio webcast can be accessed on the company’s investor relations website at https://investor.chewy.com and a replay will be accessible for 90 days following the...

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Global Industrial joined Richard Childress Racing to raise awareness for K9s For Warriors during NASCAR race weekend in Daytona....

WALNUT CREEK, Calif.--(BUSINESS WIRE)--Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA), a leading consumer goods company in the pet and garden industries, today announced that Brad Smith, Central’s Chief Financial Officer, will participate in virtual investor meetings hosted by KeyBanc Capital Markets on September 1, 2026. For registration and participation details, please contact your KeyBanc Capital Markets sales representative. A replay of the group meeting will be posted aft...

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2026 and provided its financial guidance for the fiscal year ending June 30, 2027. Highlights for the three months ended June 30, 2026 (compared to the three months ended June 30, 2025) – Net sales of $396.7 million, an increase of $18.1 million, or 5% – Net income of $21.7 million, an increase of $4.5...

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Tractor Supply Company today announced its participation in the Barclays 2026 Global Consumer Staples Conference on September 9, 2026....

EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Cronus Pharma LLC, a veterinary pharmaceutical company focused on developing high-quality, cost-effective animal health products, today announced the U.S. launch of Robenacoxib Injection, the only FDA-approved bioequivalent to ONSIOR® (robenacoxib) Injection. Robenacoxib Injection is indicated for the control of postoperative pain and inflammation associated with soft tissue surgery in dogs ≥ 4 months of age, and with orthopedic surgery, ovariohysterectomy...